Markel Group stock has delivered a 49.7% gain over the past 5 years, yet its current checks suggest only a mixed picture on value. The intrinsic value estimate from the Excess Returns model indicates the shares trade at about a 14.1% discount to that estimate, while earnings based multiples look roughly in line with the market.

• Over 5 years, a 49.7% total return indicates Markel Group has rewarded patient shareholders even though the stock has been under pressure more recently.
• Recent profit growth and strong cash generation can support the current valuation, while any setback in underwriting profitability or investment income would quickly matter for what investors are willing to pay for the stock.
• With a value score of 4 out of 6, Markel Group screens as a mixed picture rather than a clear bargain or clear overvaluation on the broader checks.

The issue now is whether that apparent discount to intrinsic value offers enough margin of safety given how the market is already pricing Markel Group today.

Is Markel Group a Bargain on Excess Returns?

The Excess Returns model looks at how much profit Markel Group can earn on its equity above the required return that shareholders expect. For Markel Group, the model uses a book value of $1,533.95 per share, a stable EPS estimate of $138.12 per share and a cost of equity of $120.40 per share. That leaves an excess return of $17.73 per share on an average return on equity of 8.15%, supported by a stable book value assumption of $1,693.82 per share.

On these inputs the model points to an intrinsic value of about $2,190.64 per share, which is roughly 14.1% above the current share price, so the stock screens as undervalued. The recent report of strong Q2 2026 results with higher underwriting profitability and investment income helps explain why the model supports a premium to where the market is pricing Markel Group today.

On balance, the Excess Returns work suggests Markel Group stock currently looks undervalued relative to its estimated intrinsic value.

Our Excess Returns analysis suggests Markel Group is undervalued by 14.1%. Track this in your watchlist or portfolio, or discover 55 more high quality undervalued stocks.

Is Markel Group Fairly Priced on Earnings?

P/E suits Markel Group because earnings are a central driver of value for an insurer with both underwriting and investment income. Right now the stock trades on a P/E of about 9.9x, compared with an Insurance industry average near 11.7x and a peer group average of roughly 11.7x as well. On raw comparisons alone, that places Markel Group at a modest discount to both its sector and peers.

A fair P/E ratio that factors in Markel Group’s size, profitability profile and risks sits closer to 10.3x. The current 9.9x level is only slightly below that mark, so the gap is small and does not point to a strong mispricing on this measure. While the recent strong Q2 2026 earnings report provides context for the current earnings base, the P/E still suggests investors are paying a price that is broadly in line with what the company’s fundamentals would point to.

On the P/E multiple, Markel Group stock looks roughly fairly valued rather than clearly cheap or expensive.

The Markel Group Narrative: What Would Justify Today's Price?

Simply Wall St Narratives for Markel Group pick up where the valuation checks leave off. They spell out the different stories that could justify Markel Group’s current price being materially higher or lower in future, based on how growth, margins and earnings might evolve. Each narrative links its number to a clear view on how the company’s growth, profitability and risks could change, which you can revisit as new results arrive. These narratives are available on Simply Wall St’s Community page.

You can add your voice to the Simply Wall St community by sharing a Narrative on Markel Group's stock that spells out your number driven case and how you see its growth, margins and execution from here. It is a chance to set out a clear view on whether Markel Group's recent underwriting and investment performance delivers on what the current share price is already assuming, and then track how that thesis holds up as new results land.

Do you think there's more to the story for Markel Group? Head over to our Community to see what others are saying!

The Bottom Line

Markel Group sits in an interesting middle ground. The Excess Returns intrinsic value estimate points to undervalued territory, while the P/E work suggests the current price is about right relative to peers. The broader checks point to a mixed overall read, so the story now hinges on whether recent underwriting and investment performance can be sustained without a meaningful slip in profitability. For you as an investor, the key question is whether that apparent discount reflects an opportunity or a fair cushion for the risks around future underwriting and investment outcomes.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.